VANI — Vivani Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1266806 ·
Last close
$1.25
Market Cap
$112.75M
52W High
$1.92
52W Low
$0.92
ADV30
208,081
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -6,874,000 | -6,370,000 | 41,639,000 | 19,894,000 | 22,672,000 |
| Mar 2026 | 0 | — | -6,817,000 | -6,780,000 | 42,353,000 | 19,749,000 | 23,268,000 |
| Dec 2025 | 0 | — | -6,810,000 | -6,633,000 | 39,393,000 | 16,232,000 | 23,663,000 |
| Sep 2025 | 0 | — | -6,725,000 | -6,530,000 | 25,046,000 | 2,628,000 | 23,737,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-25,353,000
Investing CF
$-1,171,000
Financing CF
$33,158,000
CapEx
$-1,171,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.42
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-155,313,000
Inventory
—
Receivables
$697,000
ST Investments
—
EBIT TTM
$-27,814,000
Pretax Income TTM
$-27,087,000
Interest Exp TTM
—
Analysts
3
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -27,556,000 | -26,609,000 | 39,393,000 | 23,663,000 | 15,730,000 | -24,320,000 |
| Dec 2024 | 0 | -24,677,000 | -23,486,000 | 41,561,000 | 23,951,000 | 17,610,000 | -20,786,000 |
| Dec 2023 | 0 | -26,965,000 | -25,652,000 | 45,797,000 | 25,036,000 | 20,761,000 | -23,699,000 |
| Dec 2022 | 0 | -21,241,000 | -13,889,000 | 51,130,000 | 6,822,000 | 44,308,000 | -18,787,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-27,087,000
OpCashFlow TTM
—
Assets (Latest)
$42,353,000
Forward EPS
$-0.35
Max Pain — expiry 2026-11-20
max pain strike: $1.00 · spot: $1.25 · call oi: 2,067 · put oi: 114
Expected Move to 2026-11-20:
±$0.38
(30.00%) —
implied range
$0.88 –
$1.62
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STXS | Stereotaxis, Inc. | $111.22M | $1.11 | — |
| CNXU | Conexeu Sciences Inc. | $109.72M | $3.89 | — |
| APYX | Apyx Medical Corp | $109.10M | $2.59 | — |
| LUCD | Lucid Diagnostics Inc. | $121.83M | $0.64 | — |
| QTEX | QTREX Quantum Ltd. | $104.18M | $1.87 | — |
News headlines (Yahoo Finance, 1h cache)
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
2026-08-06 12:00 · Yahoo
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
2026-07-15 23:02 · Yahoo
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
2026-07-14 20:03 · Yahoo
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
2026-07-08 11:11 · Yahoo
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
2026-07-07 11:35 · Yahoo
Vivani strikes reverse-merger agreement with ClearOne for BCI business
2026-07-03 11:40 · Yahoo
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
2026-06-25 11:30 · Yahoo
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
2026-06-22 20:03 · Yahoo
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
2026-05-28 12:30 · Yahoo
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-13 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.